npj Regenerative Medicine, an online journal created by ARMI in partnership with Nature Springer, has passed two exciting new milestones. Impact factor (IF) data recently released by Clarivate Analytics has revealed that npj Regenerative Medicine has a debut IF of 7.021 and is ranked in the first quartile for citations in both of the journal’s research categories- ‘cell & tissue engineering’ and ‘biomedical engineering’.
Both of these metrics speak to the quality of research being published in the journal, the interest in regenerative medicine as an area that is reaching maturity and heading towards more significant clinical applications, and to the increasing size of the regenerative medicine research field itself.
IF is a measure of how frequently the average article has been cited and an important indicator of the journal’s rating in the scientific community. This debut IF demonstrates that npj Regenerative Medicine is now a recognisably desirable journal for researchers and it can be anticipated that an increased number of higher calibre manuscripts will be submitted, thereby further enhancing the quality and reputation of the journal. This forecast boost will build on the steady growth the journal has seen, with an annual increase in the number of published manuscripts.
This success has been five years in the making. As Silvio Tiziani, then Chief Operating Officer at ARMI recalls, ‘The journal was launched in October 2015 after a gap in the literature was identified by Nature Springer, the publisher of the prestigious Nature stable of scientific journals. The field of regenerative medicine was emerging and showing promise, but relatively few journals exclusively published the exciting findings that regenerative medicine researchers were able to report.’
Nature Springer, recognising ARMI’s research and leadership and global impact, invited the Institute to create a new journal in partnership with them, that would focus on the latest scientific development in this growing area of research.
‘Nature Springer, recognising ARMI’s research and leadership and global impact, invited the Institute to create a new journal in partnership with them, that would focus on the latest scientific development in this growing area of research. We recognised it immediately as a great opportunity for the Institute and with the support of Professor Ross Coppel, the Medical Faculty’s Associate Dean for Research, we were able to enter into the partnership as a joint venture with Nature Springer. The journal’s founding chief editor, and former Institute Director, Professor Nadia Rosenthal, has been able to put together a stellar editorial committee. Under her stewardship, the journal has gone from strength to strength.’
Today, its reputation as a journal dedicated to publishing the highest quality research, from fundamental discovery to clinical application, into ways to help the human body repair, replace, restore and regenerate damaged tissues and organs, continues to strengthen.
Congratulations to the npj Regenerative Medicine team and the Institute on this tremendous achievement!